| Identification | Back Directory | [Name]
3',5'-Dimethoxytricetin 7-O-β-D-glucopypranoside | [CAS]
32769-01-0 | [Synonyms]
Tricin 7-glucoside
3',5'-Dimethoxytricetin 7-O-β-D-glucopypranoside
7-[(β-D-Glucopyranosyl)oxy]-4',5-dihydroxy-3',5'-dimethoxyflavone
2-(4-Hydroxy-3,5-dimethoxyphenyl)-7-(β-D-glucopyranosyloxy)-5-hydroxy-4H-1-benzopyran-4-one | [Molecular Formula]
C21H20O10 | [MOL File]
32769-01-0.mol | [Molecular Weight]
432.379 |
| Chemical Properties | Back Directory | [Melting point ]
244-246 °C | [Boiling point ]
819.2±65.0 °C(Predicted) | [density ]
1.582±0.06 g/cm3(Predicted) | [pka]
6.08±0.40(Predicted) | [InChIKey]
KMOUJOKENFFTPU-LKLLPNDVNA-N | [SMILES]
C12C=C(C=C(O)C=1C(=O)C=C(C1=CC=C(O)C=C1)O2)O[C@H]1[C@H](O)[C@H]([C@H](O)[C@@H](CO)O1)O |&1:20,21,23,24,26,r| |
| Hazard Information | Back Directory | [Uses]
Tricine 7-Glucoside can be used by itself or in combination with other agents against various strains of bacteria and to treat cancer. | [Definition]
ChEBI: Tricin 7-O-beta-D-glucoside is a glycosyloxyflavone that is 3',5'-di-O-methyltricetin (tricin) in which the phenolic hydrogen at position 7 has been replaced by a beta-D-glucopyranosyl group. It has a role as a plant metabolite, a radical scavenger and a xenobiotic metabolite. It is a beta-D-glucoside, a dihydroxyflavone, a dimethoxyflavone, a glycosyloxyflavone, a monosaccharide derivative and a polyphenol. It is functionally related to a 3',5'-di-O-methyltricetin. | [in vivo]
Tricin 7-O-β-D-glucopyranoside (50, 100, 200 and 400 mg/kg; p.o.) shows neuroprotective potential in rats with ischemia and reperfusion (I/R)[1]. | Animal Model: | Adult male Sprague-Dawley rats[1] | | Dosage: | 50, 100, 200 and 400 mg/kg | | Administration: | P.o. | | Result: | Decreased neurological deficit scores, reduced brain infarct volume and brain water content, inhibited NF-κB activation and reduced HMGB1 expression. |
|
|
|